InnoMax MedTech Showcases Innovations at Medtec China 2025

InnoMax Medical Technology Co., Ltd. (InnoMax MedTech) made a significant impact at Medtec China 2025, held from September 24 to 26 in Shanghai. The company showcased a diverse range of proprietary products, including its notable Portable Mesh Nebulizer, portable oxygen concentrator, AI-enabled sleep-assist device, injection pens, and blood glucose meters. These innovations attracted considerable attention from healthcare and medical technology professionals attending the event.

During a live interview on September 25, Jackson Shih, Chairman of InnoMax MedTech, highlighted the company’s extensive product portfolio, which encompasses key healthcare segments such as in-vitro diagnostics, medical imaging, respiratory care, smart rehabilitation, and wearable health devices. He emphasized the importance of providing end-to-end, precision development and manufacturing services for medical devices to clients across the globe.

Shih pointed out the challenges faced by startups in managing the entire process from research and development to market entry independently. “This is precisely why InnoMax MedTech was founded,” he stated. The company aims to leverage its comprehensive capabilities to assist more firms through the complete product lifecycle, from development and manufacturing to regulatory submission. This approach is designed to help clients overcome technical and execution hurdles.

Confidentiality and intellectual property protection are paramount for InnoMax MedTech’s clients. Shih elaborated on the company’s comprehensive confidentiality program, which focuses on four key areas: institutional protocols, information security measures, process controls, and personnel management. These measures work together to provide layered protection, including preventive controls, real-time monitoring, and post-incident traceability, ensuring the security of client data and the preservation of technology exclusivity.

China has emerged as a major player in the global Contract Development and Manufacturing Organization (CDMO) market, increasingly attracting outsourced global production. The country benefits from cost efficiencies, a strong manufacturing foundation, and advancing technical capabilities. Shih noted, “InnoMax MedTech has the capacity to deliver fully integrated medical device solutions.” He expressed the company’s commitment to deepening its expertise, expanding its global footprint, and strengthening international service capabilities.

The overarching goal of InnoMax MedTech is to provide clients with more efficient, end-to-end solutions, establishing a world-class, open, and sustainable medical device manufacturing platform. As the company continues to innovate and expand, it aims to address the evolving needs of the healthcare industry and contribute to advancements in medical technology.